Applied Therapeutics Inc. (APLT) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Applied Therapeutics Inc.

    NASDAQ: APLT · Real-Time Price · USD
    1.24
    0.68 (121.35%)
    At close: Sep 26, 2025, 3:59 PM
    1.17
    -5.65%
    After-hours: Sep 26, 2025, 07:59 PM EDT

    Applied Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 455K 9.99M n/a n/a
    Cost of Revenue
    		 425K 353K 441K 415K
    Gross Profit
    		 455K 9.99M -441K -415K
    Operating Income
    		 -104.3M -64.53M -82.95M -105.62M
    Interest Income
    		 3.53M 1.37M 685K 555K
    Pretax Income
    		 -105.62M -119.76M -82.51M -105.58M
    Net Income
    		 -105.62M -119.76M -82.51M -105.58M
    Selling & General & Admin
    		 56.01M 20.62M 27.32M 43.05M
    Research & Development
    		 48.74M 53.91M 55.63M 62.57M
    Other Expenses
    		 n/a n/a -441K n/a
    Operating Expenses
    		 104.75M 74.53M 82.51M 105.62M
    Interest Expense
    		 n/a n/a n/a 555K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 104.75M 74.53M 82.95M 105.62M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 139.53M 84.24M 37.83M 25.6M
    Shares Outstanding (Diluted)
    		 139.53M 84.24M 37.83M 25.6M
    EPS (Basic)
    		 -0.76 -1.42 -2.18 -4.12
    EPS (Diluted)
    		 -0.76 -1.42 -2.18 -4.12
    EBITDA
    		 -103.87M -64.18M -82.07M -105.17M
    EBIT
    		 -104.3M -64.53M -82.51M -105.58M
    Depreciation & Amortization
    		 426K 353K 441K 415K

    Add to Watchlist